These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2873174)

  • 1. A 2-year survey of Branhamella catarrhalis in a general hospital.
    Smith JM; Lockwood BM
    J Hosp Infect; 1986 May; 7(3):277-82. PubMed ID: 2873174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The occurrence of Branhamella catarrhalis and other commensal Neisseriaceae in clinical sputum specimens in Lagos, Nigeria.
    Obi MC; Animashaun T; Odugbemi T
    Eur J Epidemiol; 1990 Sep; 6(3):323-5. PubMed ID: 2123801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease.
    Pollard JA; Wallace RJ; Nash DR; Luman JI; Wilson RW
    Drugs; 1986; 31 Suppl 3():103-8. PubMed ID: 3488188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of respiratory tract pathogens and antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated between 1990 and 1993.
    Nishioka K; Ogihara H; Ohno I; Tanno Y; Shirato K
    Tohoku J Exp Med; 1996 Jun; 179(2):111-21. PubMed ID: 8875767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchopulmonary infection due to Branhamella catarrhalis.
    McLeod DT; Ahmad F; Power JT; Calder MA; Seaton A
    Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1446-7. PubMed ID: 6416451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Branhamella (Moraxella) catarrhalis--a clinically relevant pathogen of bronchopulmonary diseases?].
    Radzuweit S; Kalich R
    Z Erkr Atmungsorgane; 1991; 177(1-2):82-7. PubMed ID: 1808857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease.
    Nicotra B; Rivera M; Luman JI; Wallace RJ
    Arch Intern Med; 1986 May; 146(5):890-3. PubMed ID: 3963981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of Branhamella catarrhalis from sputum and tracheal aspirate.
    Aitken JM; Thornley PE
    J Clin Microbiol; 1983 Nov; 18(5):1262-3. PubMed ID: 6643672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoelectric focusing of beta-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United States.
    Nash DR; Wallace RJ; Steingrube VA; Shurin PA
    Drugs; 1986; 31 Suppl 3():48-54. PubMed ID: 3488197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
    Kallings I; Bengtsson S; Christensen P; Holm SE; Lind L; Kalin M
    Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolation of Branhamella catarrhalis from sputum and clinical features of bronchopulmonary infection due to Branhamella catarrhalis].
    Kinoshita A; Mukae H; Takase T; Ishino T; Kohno S; Kanda T; Yamaguchi K; Hirota M; Hara K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jun; 28(6):875-81. PubMed ID: 2120499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa.
    Powell M; McVey D; Kassim MH; Chen HY; Williams JD
    J Antimicrob Chemother; 1991 Aug; 28(2):249-59. PubMed ID: 1778856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections.
    Saito A; Yamaguchi K; Shigeno Y; Kohno S; Shigeno H; Kusano N; Dotsu Y; Hara K
    Drugs; 1986; 31 Suppl 3():87-92. PubMed ID: 3488201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Branhamella catarrhalis as an indirect pathogen.
    Wardle JK
    Drugs; 1986; 31 Suppl 3():93-6. PubMed ID: 3732085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Branhamella catarrhalis in infectious pathology of the respiratory tract].
    Le Faou A; Rio A
    Presse Med; 1983 Sep; 12(33):2035-7. PubMed ID: 6226017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent trends in incidence of respiratory tract pathogens and antimicrobial susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis isolated in 1994 and 1995].
    Nishioka K; Ogihara H; Ohno I; Shirato K
    Jpn J Antibiot; 1997 Sep; 50(9):768-75. PubMed ID: 9394237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Branhamella catarrhalis: an unappreciated pulmonary pathogen.
    Roth RM; Gleckman RA; Hibert DM
    Am Fam Physician; 1984 Oct; 30(4):169-73. PubMed ID: 6333806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of respiratory infection caused by Branhamella catarrhalis with special reference to beta-lactamase producing strains.
    Nagatake T
    Tohoku J Exp Med; 1985 Sep; 147(1):1-13. PubMed ID: 3000026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiological considerations of the etiological agents of lower respiratory tract infections.
    Pellegrino MB; Privitera A; Primavera A; Puntorieri M; Nicoletti A; Stefani S; Nicoletti G
    J Chemother; 1992 Aug; 4(4):211-5. PubMed ID: 1403075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.